These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 33832059)
21. Development of an immune-related prognostic index associated with osteosarcoma. Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790 [TBL] [Abstract][Full Text] [Related]
22. Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients. Li LQ; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Khader MA; Jia-Wen ; Tao-Liu ; Li JZ Aging (Albany NY); 2020 Nov; 12(22):22906-22926. PubMed ID: 33203792 [TBL] [Abstract][Full Text] [Related]
23. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets. Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873 [TBL] [Abstract][Full Text] [Related]
24. Machine learning survival prediction using tumor lipid metabolism genes for osteosarcoma. Li S; Zheng Z; Wang B Sci Rep; 2024 Jun; 14(1):12934. PubMed ID: 38839983 [TBL] [Abstract][Full Text] [Related]
25. A Four-Pseudogene Classifier Identified by Machine Learning Serves as a Novel Prognostic Marker for Survival of Osteosarcoma. Liu F; Xing L; Zhang X; Zhang X Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146489 [TBL] [Abstract][Full Text] [Related]
26. A four-methylated LncRNA signature predicts survival of osteosarcoma patients based on machine learning. Deng Y; Yuan W; Ren E; Wu Z; Zhang G; Xie Q Genomics; 2021 Jan; 113(1 Pt 2):785-794. PubMed ID: 33069828 [TBL] [Abstract][Full Text] [Related]
27. Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes. Qi W; Yan Q; Lv M; Song D; Wang X; Tian K Pathol Oncol Res; 2021; 27():1609782. PubMed ID: 34335109 [No Abstract] [Full Text] [Related]
28. Development of a novel six DNA damage response-related prognostic signature in osteosarcoma. Li T; Tang Z; Li S; Lu M Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):110-115. PubMed ID: 38650147 [TBL] [Abstract][Full Text] [Related]
29. An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets. Hill KE; Kelly AD; Kuijjer ML; Barry W; Rattani A; Garbutt CC; Kissick H; Janeway K; Perez-Atayde A; Goldsmith J; Gebhardt MC; Arredouani MS; Cote G; Hornicek F; Choy E; Duan Z; Quackenbush J; Haibe-Kains B; Spentzos D J Hematol Oncol; 2017 May; 10(1):107. PubMed ID: 28506242 [TBL] [Abstract][Full Text] [Related]
30. Establishment of an Autophagy-Related Clinical Prognosis Model for Predicting the Overall Survival of Osteosarcoma. Li J; Tang X; Du Y; Dong J; Zhao Z; Hu H; Song T; Guo J; Wang Y; Xu T; Shao C; Sheng Y; Xi Y Biomed Res Int; 2021; 2021():5428425. PubMed ID: 34604383 [TBL] [Abstract][Full Text] [Related]
31. Identification of a novel glycolysis-related gene signature for predicting the prognosis of osteosarcoma patients. Yang M; Ma X; Wang Z; Zhang T; Hua Y; Cai Z Aging (Albany NY); 2021 May; 13(9):12896-12918. PubMed ID: 33952718 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA-375 as a potential serum biomarker for the diagnosis, prognosis, and chemosensitivity prediction of osteosarcoma. Liu W; Zhao X; Zhang YJ; Fang GW; Xue Y J Int Med Res; 2018 Mar; 46(3):975-983. PubMed ID: 29115164 [TBL] [Abstract][Full Text] [Related]
33. Development of a Machine Learning-Based Autophagy-Related lncRNA Signature to Improve Prognosis Prediction in Osteosarcoma Patients. Zhang GZ; Wu ZL; Li CY; Ren EH; Yuan WH; Deng YJ; Xie QQ Front Mol Biosci; 2021; 8():615084. PubMed ID: 34095215 [TBL] [Abstract][Full Text] [Related]
34. CRISPR-Cas9 screening identified lethal genes enriched in necroptosis pathway and of prognosis significance in osteosarcoma. Cheng L; Xiong W; Li S; Wang G; Zhou J; Li H J Gene Med; 2023 Dec; 25(12):e3563. PubMed ID: 37421290 [TBL] [Abstract][Full Text] [Related]
35. Transcriptome Analysis Identifies Novel Prognostic Genes in Osteosarcoma. Chen J; Guo X; Zeng G; Liu J; Zhao B Comput Math Methods Med; 2020; 2020():8081973. PubMed ID: 33082842 [TBL] [Abstract][Full Text] [Related]
36. Exploration of Immune-Related Gene Expression in Osteosarcoma and Association With Outcomes. Liu W; Xie X; Qi Y; Wu J JAMA Netw Open; 2021 Aug; 4(8):e2119132. PubMed ID: 34342651 [TBL] [Abstract][Full Text] [Related]
37. Development of novel gene signatures for the risk stratification of prognosis and diagnostic prediction of osteosarcoma patients using bioinformatics analysis. Li G; Huang B; Wu H; Zhang H Transl Cancer Res; 2022 Jul; 11(7):2374-2387. PubMed ID: 35966307 [TBL] [Abstract][Full Text] [Related]
38. Identification of the Novel Target Genes for Osteosarcoma Therapy Based on Comprehensive Bioinformatic Analysis. Zhou X; Fan Y; Ye W; Jia B; Yang Y; Liu Y DNA Cell Biol; 2020 Jul; 39(7):1172-1180. PubMed ID: 32584170 [TBL] [Abstract][Full Text] [Related]
39. Identification of N6-methylandenosine related LncRNAs biomarkers associated with the overall survival of osteosarcoma. Zhang P; Xu K; Wang J; Zhang J; Quan H BMC Cancer; 2021 Dec; 21(1):1285. PubMed ID: 34852770 [TBL] [Abstract][Full Text] [Related]
40. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients. Yu J; Mao W; Xu B; Chen M Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]